LOS ANGELES CAPITAL MANAGEMENT LLC
Position in STOK — Stoke Therapeutics, Inc.
CIK 1177206
LOS ANGELES, CA
Position in STOK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,164,766
+$172,370 QoQ
Shares Held
35,598
+16.8% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#90
of 198 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in STOK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. STOK ranks #33 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in STOK
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,164,766 | 35,598 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $992,396 | 30,479 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $292,198 | 9,206 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $217,680 | 9,263 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $223,765 | 19,715 | Shares | Sole | 2025-08-07 | |
| 2024-12-31 | $479,121 | 43,438 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,265,931 | 103,005 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $901,995 | 66,765 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $840,469 | 62,257 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $327,471 | 62,257 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $188,123 | 47,747 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $521,688 | 49,077 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $325,328 | 39,055 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $373,011 | 40,413 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $362,383 | 28,223 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $372,825 | 28,223 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $484,423 | 23,013 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $446,285 | 18,603 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $511,013 | 20,087 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $576,158 | 17,117 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||